Phathom Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Phathom Pharmaceuticals

08/11/2022 23:46

* Phathom Pharmaceuticals Inc  PHAT.OQ  reported a quarterly
adjusted loss of $1.32​​ per share for the quarter ended in
September. The mean expectation of six analysts for the quarter
was for a loss of $1.32 per share.
    * Reported revenue was zero​; analysts expected $200.00
thousand. 
    * Phathom Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of $1.32​.
    * The mean earnings estimate of analysts had fallen by
about 6.5%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Phathom Pharmaceuticals Inc shares had fallen by 8.1% this
quarter and lost 48.2% so far this year.
    * The company reported a quarterly loss of $51.09 million.
    * Wall Street's median 12-month price target for Phathom
Pharmaceuticals Inc is $34.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
8 at 11:46 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -1.32          -1.32          Met
 Jun. 30 2022      -1.03          -1.33          Missed
 Mar. 31 2022      -0.97          -1.07          Missed
 Dec. 31 2021      -1.03          -0.95          Beat